CREBRF变异与关岛和塞班岛太平洋岛民肥胖及糖尿病的关联
在2022名关岛和塞班岛太平洋岛民(主要为马里亚纳和密克罗尼西亚人群)的社区横断面研究中,CREBRF rs12513649的G等位基因和rs373863828的A等位基因均与更高的BMI相关,同时与更低的糖尿病风险相关;Meta分析合并波利尼西亚人群数据后进一步证实了这些关联,提示这些变异参与大洋洲人群肥胖和糖尿病风险。
要点
- CREBRF rs12513649 G等位基因频率7.7%,rs373863828 A等位基因频率4.2%,在不同人群间差异较大。
- rs12513649 G等位基因与BMI升高(β=1.55 kg/m2,p=0.0026)及糖尿病风险降低(OR=0.63,p=0.0063)相关。
- rs373863828 A等位基因与BMI升高(β=1.48 kg/m2,p=0.033)及糖尿病风险降低(OR=0.49,p=0.0022)相关。
核心结论
- CREBRF变异与太平洋岛民更高的BMI和更低的糖尿病风险相关,提示这些变异参与大洋洲人群肥胖和糖尿病风险。
研究设计与样本
- 社区横断面研究,纳入2022名关岛和塞班岛的太平洋岛民(主要为马里亚纳和密克罗尼西亚人群),对CREBRF rs12513649和rs373863828进行基因分型。
主要发现
- rs12513649 G等位基因总体频率7.7%,在不同马里亚纳和密克罗尼西亚人群中范围为2.2%至20.7%。
- rs373863828 A等位基因总体频率4.2%,范围为1.1%至5.4%。
- rs12513649 G等位基因与BMI升高相关(β=1.55 kg/m2每拷贝,p=0.0026),并与糖尿病风险降低相关(OR=0.63每拷贝,p=0.0063)。
- rs373863828 A等位基因与BMI升高相关(β=1.48 kg/m2,p=0.033),并与糖尿病风险降低相关(OR=0.49,p=0.0022)。
- Meta分析合并当前结果与既往波利尼西亚人群结果,显示rs373863828 A等位基因与BMI(β=1.38 kg/m2,p=2.5×10-29)和糖尿病(OR=0.65,p=1.5×10-13)强关联。
临床怎么用
- 在太平洋岛民中,CREBRF变异携带者可能具有更高的BMI但更低的糖尿病风险,需结合遗传背景解读肥胖与代谢风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: Variants in CREBRF (rs12513649 and rs373863828) have been strongly associated with increased BMI and decreased risk of type 2 diabetes in Polynesian populations; the A allele at rs373863828 is common in Polynesians but rare in most other global populations. The aim of the present study was to assess the association of CREBRF variants with obesity and diabetes in Pacific Islander (largely Marianas and Micronesian) populations from Guam and Saipan. METHODS: CREBRF rs12513649 and rs373863828 were genotyped in 2022 participants in a community-based cross-sectional study designed to identify determinants of diabetes and end-stage renal disease (ESRD). Associations were analysed with adjustment for age, sex, ESRD and the first four genetic principal components from a genome-wide association study (to account for population stratification); a genomic control procedure was used to account for residual stratification. RESULTS: The G allele at rs12513649 had an overall frequency of 7.7%, which varied from 2.2% to 20.7% across different Marianas and Micronesian populations; overall frequency of the A allele at rs373863828 was 4.2% (range: 1.1-5.4%). The G allele at rs12513649 was associated with higher BMI (β = 1.55 kg/m2 per copy; p = 0.0026) as was the A allele at rs373863828 (β = 1.48 kg/m2, p = 0.033). The same alleles were associated with lower risk of diabetes (OR per copy: 0.63 [p = 0.0063] and 0.49 [p = 0.0022], respectively). Meta-analyses combining the current results with previous results in Polynesians showed a strong association between the A allele at rs373863828 and BMI (β = 1.38 kg/m2; p = 2.5 × 10-29) and diabetes (OR 0.65, p = 1.5 × 10-13). CONCLUSIONS/INTERPRETATION: These results confirm the associations of CREBRF variants with higher BMI and lower risk of diabetes and, importantly, they suggest that these variants contribute to the risk of obesity and diabetes in Oceanic populations.
引用
- Hanson RL, Safabakhsh S, Curtis JM, et al. Association of CREBRF variants with obesity and diabetes in Pacific Islanders from Guam and Saipan. Diabetologia. 2019. PMID: 31280340. doi:10.1007/s00125-019-4932-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。